|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"shan y s"
Showing items 51-75 of 95 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-04-28T07:25:25Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; CHIH-HUNG HSU; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Ch'Ang H.-J. ;Lin Y.-L. ;Wang H.-P. ;Chiu Y.-F. ;Chang M.-C. ;Chih-Hung Hsu ;Tien Y.-W. ;Chen J.-S. ;Hsieh R.-K. ;Lin P.-W. ;Shan Y.-S. ;Cheng A.-L. ;Chang J.-Y. ;Whang-Peng J. ;Hwang T.-L. ;Chen L.-T. |
| 臺大學術典藏 |
2020-04-10T12:51:03Z |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chen L.-T.; Huang S.-F.; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Chiun Hsu; Chiang N.-J.; Chiang N.-J.;Chiun Hsu;Chen J.-S.;Tsou H.-H.;Shen Y.-Y.;Chao Y.;Chen M.-H.;Yeh T.-S.;Shan Y.-S.;Huang S.-F.;Chen L.-T. |
| 臺大學術典藏 |
2020-03-07T06:48:18Z |
Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma
|
Ch'Ang H.-J.; Yu W.C.Y.; Tsai K.K.C.; Lin C.-Y.; Hsu C.-F.; Shan Y.-S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO; Chang V.H.S. |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
Kr?ppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma
|
Chang V.H.S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO; Shan Y.-S.; Hsu C.-F.; Lin C.-Y.; Tsai K.K.C.; Yu W.C.Y.; Ch'Ang H.-J. |
| 臺大學術典藏 |
2020-02-20T06:53:13Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Shan Y.-S.; Cheng A.-L.; Lin P.-W.; Chen J.-S.; Hsieh R.-K.; YU-WEN TIEN; Ch'Ang H.-J.;Lin Y.-L.;Wang H.-P.;Chiu Y.-F.;Chang M.-C.;Hsu C.-H.;Yu-Wen Tien;Chen J.-S.;Hsieh R.-K.;Lin P.-W.;Shan Y.-S.;Cheng A.-L.;Chang J.-Y.;Whang-Peng J.;Hwang T.-L.;Chen L.-T.; Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Tsou H.-H.; CHIUN HSU; Yen C.-J.; Yang S.-H.; Chen M.-H.; Chiang N.-J. |
| 臺大學術典藏 |
2020 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study
|
Shen W.-C.; CHIUN HSU; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Hsiao H.-H.; Yang S.-H.; Tsai K.K.; Hsiao C.-F.; Chiang N.-J. |
| 國立成功大學 |
2020 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, Y.-S.;Chen, L.-T.;Wu, J.-S.;Chang, Y.-F.;Lee, C.-T.;Wu, C.-H.;Chiang, N.-J.;Huang, Huang H.-E.;Yen, C.-J.;Chao, Y.-J.;Tsai, H.-J.;Chen, Chen C.-Y.;Kang, J.-W.;Kuo, C.-F.;Tsai, C.-R.;Weng, Y.-L.;Yang, H.-C.;Liu, H.-C.;Chang, J.S. |
| 國立成功大學 |
2020 |
OSU-A9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase M2 protein levels
|
Chiu, Chiu C.-F.;Weng, J.-R.;Lee, S.-L.;Wu, C.-Y.;Chu, P.-C.;Shan, Y.-S.;Yang, H.-R.;Bai, L.-Y. |
| 國立成功大學 |
2020 |
Risk factors for pancreatic fistula grade C after pancreatoduodenectomy: A large prospective, multicenter Japan-Taiwan collaboration study
|
Hirono, S.;Shimokawa, T.;Nagakawa, Y.;Shyr, Y.-M.;Kawai, M.;Matsumoto, I.;Satoi, Satoi S.;Yoshitomi, H.;Okabayashi, T.;Motoi, F.;Amano, R.;Murakami, Y.;Hirano, S.;Kawamoto, Kawamoto K.;Nakamori, S.;Shan, Y.-S.;Kobayashi, S.;Nitta, H.;Matsukawa, H.;Uchiyama, K.;Hsu, C.-P.;Kitami, C.;Yamamoto, M.;Hwang, T.-L.;Yamaue, H. |
| 國立成功大學 |
2020 |
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
|
Bang, Y.-J.;Li, C.-P.;Lee, K.-H.;Chiu, Chiu C.-F.;Park, J.O.;Shan, Y.-S.;Kim, J.S.;Chen, J.-S.;Shim, H.-J.;Rau, K.-M.;Choi, H.J.;Oh, D.-Y.;Belanger, Belanger B.;Chen, L.-T. |
| 國立成功大學 |
2020 |
Cancer-derived transforming growth factor-β modulates tumor-associated macrophages in ampullary cancer
|
Cheng, L.-C.;Chao, Y.-J.;Wang, C.-Y.;Phan, N.N.;Chen, Y.-L.;Wang, T.-W.;Hsu, Hsu H.-P.;Lin, Y.-J.;Shan, Y.-S.;Lai, M.-D. |
| 國立成功大學 |
2020 |
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
|
Chen, M.-H.;Chou, W.-C.;Hsiao, C.-F.;Jiang, S.S.;Tsai, H.-J.;Liu, Y.-C.;Hsu, C.;Shan, Y.-S.;Hung, Y.-P.;Hsich, C.-H.;Chiu, Chiu C.-H.;Liu, T.-C.;Cho, S.-F.;Liu, T.-W.;Chao, Y. |
| 國立成功大學 |
2020 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
|
Chiang, N.-J.;Tsai, K.K.;Hsiao, C.-F.;Yang, S.-H.;Hsiao, Hsiao H.-H.;Shen, W.-C.;Hsu, C.;Lin, Y.-L.;Chen, J.-S.;Shan, Y.-S.;Chen, L.-T. |
| 國立成功大學 |
2020 |
Loss of EGR-1 uncouples compensatory responses of pancreatic β cells
|
Leu, S.-Y.;Kuo, L.-H.;Weng, Weng W.-T.;Lien, I.-C.;Yang, C.-C.;Hsieh, T.-T.;Cheng, Y.-N.;Chien, P.-H.;Ho, L.-C.;Chen, S.-H.;Shan, Y.-S.;Chen, Y.-W.;Tsai, P.-J.;Sung, J.-M.;Tsai, Y.-S. |
| 國立成功大學 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, N.-J.;Chen, M.-H.;Yang, S.-H.;Hsu, C.;Yen, C.-J.;Tsou, H.-H.;Su, Y.-Y.;Chen, J.-S.;Shan, Y.-S.;Chen, L.-T. |
| 國立成功大學 |
2020 |
An integrated microfluidic platform for cholangiocarcinoma diagnosis from clinical bile juice samples by utilizing multiple affinity reagents
|
Lu, T.-H.;Chiang, N.-J.;Huang, C.-J.;Gopinathan, P.;Tu, H.-C.;Tsai, Y.-C.;Shan, Y.-S.;Hung, S.-C.;Lee, G.-B. |
| 國立成功大學 |
2019 |
A Simple Method of Intracorporeal "w-shaped" Liver Retraction Technique for Minimally Invasive Gastric Cancer Surgery
|
Wang, C.-J.;Chao, Y.-J.;Sy, E.D.;Shan, Y.-S. |
| 國立成功大學 |
2019 |
Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression
|
Hsu, M.-C.;Pan, M.-R.;Chu, P.-Y.;Tsai, Y.-L.;Tsai, C.-H.;Shan, Y.-S.;Chen, L.-T.;Hung, W.-C. |
| 國立成功大學 |
2019 |
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer
|
Weng, C.-C.;Hsieh, M.-J.;Wu, C.-C.;Lin, Y.-C.;Shan, Y.-S.;Hung, W.-C.;Chen, L.-T.;Cheng, K.-H. |
| 國立成功大學 |
2019 |
The Epidemiology of Gastric Cancers in the Era of Helicobacter pylori Eradication: A nationwide cancer registry-based study in Taiwan
|
Chang, J.S.;Kuo, S.-H.;Chu, P.-Y.;Shan, Y.-S.;Tsai, C.-R.;Tsai, H.-J.;Chen, L.-T. |
| 國立成功大學 |
2019 |
The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis
|
Hsu, C.-C.;Liao, W.-Y.;Chan, T.-S.;Chen, W.-Y.;Lee, C.-T.;Shan, Y.-S.;Huang, P.-J.;Hou, Y.-C.;Li, C.-R.;Tsai, K.K. |
| 國立成功大學 |
2019 |
β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer
|
Kuo, T.-L.;Cheng, K.-H.;Shan, Y.-S.;Chen, L.-T.;Hung, W.-C. |
| 國立成功大學 |
2019 |
Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
|
Yu, H.-H.;Hsieh, M.-C.;Wu, S.-Y.;Sy, E.D.;Shan, Y.-S. |
| 國立成功大學 |
2019 |
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
|
Hsu, M.-C.;Tsai, Y.-L.;Lin, C.-H.;Pan, M.-R.;Shan, Y.-S.;Cheng, T.-Y.;Cheng, S.H.-C.;Chen, L.-T.;Hung, W.-C. |
Showing items 51-75 of 95 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
|
